Fund profile
Tickers
LYFCX, LYFIX, LYFAX
Fund manager
Total assets
$104.36 mm
Liabilities
$1.13 mm
Net assets
$103.23 mm
Number of holdings
61.00
61 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
FIRST AM-TR OB-X | 6.38 mm | 6.38 mm principal | 6.18 | Short-term investment vehicle | Long | USA |
PFE Pfizer Inc. | 4.86 mm | 175.00 k shares | 4.70 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings Inc | 4.10 mm | 122.00 k shares | 3.97 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 3.68 mm | 16.00 k shares | 3.56 | Common equity | Long | USA |
PCRX Pacira BioSciences Inc | 3.43 mm | 117.50 k shares | 3.33 | Common equity | Long | USA |
BCRX Biocryst Pharmaceuticals Inc. | 3.43 mm | 675.00 k shares | 3.32 | Common equity | Long | USA |
GLPG Galapagos NV | 3.38 mm | 105.00 k shares | 3.28 | Common equity | Long | Belgium |
ARGX Argen X SE | 3.15 mm | 8.00 k shares | 3.05 | Common equity | Long | Netherlands |
NARI Inari Medical Inc | 3.02 mm | 63.00 k shares | 2.93 | Common equity | Long | USA |
DCGO DocGo Inc | 2.63 mm | 650.00 k shares | 2.54 | Common equity | Long | USA |
BEIGENE LTD-ADR
|
2.62 mm | 16.75 k shares | 2.54 | Common equity | Long | Cayman Islands |
AXSM Axsome Therapeutics Inc | 2.59 mm | 32.50 k shares | 2.51 | Common equity | Long | USA |
QURE uniQure N.V. | 2.39 mm | 460.00 k shares | 2.32 | Common equity | Long | Netherlands |
CHRS Coherus Biosciences Inc | 2.39 mm | 1.00 mm shares | 2.32 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals Inc | 2.36 mm | 94.00 k shares | 2.29 | Common equity | Long | USA |
UROGEN PHARMA LT
|
2.16 mm | 143.90 k shares | 2.09 | Common equity | Long | Israel |
CORT Corcept Therapeutics Inc | 2.14 mm | 85.00 k shares | 2.07 | Common equity | Long | USA |
CATX Perspective Therapeutics Inc | 2.09 mm | 1.76 mm shares | 2.03 | Common equity | Long | USA |
FOLD Amicus Therapeutics Inc | 2.06 mm | 175.00 k shares | 2.00 | Common equity | Long | USA |
EXAS Exact Sciences Corp. | 2.00 mm | 29.00 k shares | 1.94 | Common equity | Long | USA |
RPRX Royalty Pharma plc - Ordinary Shares | 1.82 mm | 60.00 k shares | 1.77 | Common equity | Long | UK |
CERE Cerevel Therapeutics Holdings Inc | 1.80 mm | 42.50 k shares | 1.74 | Common equity | Long | USA |
MDT Medtronic Plc | 1.79 mm | 20.50 k shares | 1.73 | Common equity | Long | Ireland |
ROG-SE Roche Holding AG | 1.74 mm | 54.50 k shares | 1.69 | Common equity | Long | Switzerland |
KPTI Karyopharm Therapeutics Inc | 1.70 mm | 1.13 mm shares | 1.65 | Common equity | Long | USA |
CLDX Celldex Therapeutics Inc. | 1.62 mm | 38.50 k shares | 1.57 | Common equity | Long | USA |
KALV KalVista Pharmaceuticals Inc | 1.54 mm | 130.00 k shares | 1.49 | Common equity | Long | USA |
DVAX Dynavax Technologies Corp. | 1.52 mm | 122.50 k shares | 1.47 | Common equity | Long | USA |
GSK GSK Plc | 1.50 mm | 35.00 k shares | 1.45 | Common equity | Long | UK |
BCYC Bicycle Therapeutics Plc | 1.49 mm | 60.00 k shares | 1.45 | Common equity | Long | UK |
AVBP ArriVent BioPharma Inc. | 1.48 mm | 83.00 k shares | 1.44 | Common equity | Long | USA |
EMBC Embecta Corp | 1.48 mm | 111.50 k shares | 1.43 | Common equity | Long | USA |
VKTX Viking Therapeutics Inc | 1.48 mm | 18.00 k shares | 1.43 | Common equity | Long | USA |
TRML Tourmaline Bio Inc | 1.40 mm | 61.10 k shares | 1.36 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 1.38 mm | 20.00 k shares | 1.34 | Common equity | Long | USA |
VYNE VYNE Therapeutics Inc | 1.37 mm | 445.00 k shares | 1.32 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 1.35 mm | 15.50 k shares | 1.31 | Common equity | Long | USA |
IMVT Immunovant Inc | 1.23 mm | 38.00 k shares | 1.19 | Common equity | Long | USA |
RVNC Revance Therapeutics Inc | 1.21 mm | 245.00 k shares | 1.17 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc | 1.18 mm | 27.50 k shares | 1.14 | Common equity | Long | Cayman Islands |
CABA Cabaletta Bio Inc | 1.11 mm | 65.00 k shares | 1.07 | Common equity | Long | USA |
JAZZ Jazz Pharmaceuticals plc | 1.02 mm | 8.50 k shares | 0.99 | Common equity | Long | Ireland |
SGMT Sagimet Biosciences Inc. | 1.00 mm | 185.00 k shares | 0.97 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 965.44 k | 7.00 k shares | 0.94 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd | 948.60 k | 90.00 k shares | 0.92 | Common equity | Long | Bermuda |
DCPH Deciphera Pharmaceuticals Inc | 943.80 k | 60.00 k shares | 0.91 | Common equity | Long | USA |
VRNA Verona Pharma Plc | 901.04 k | 56.00 k shares | 0.87 | Common equity | Long | UK |
ACAD Acadia Pharmaceuticals Inc | 832.05 k | 45.00 k shares | 0.81 | Common equity | Long | USA |
SNY Sanofi | 729.00 k | 15.00 k shares | 0.71 | Common equity | Long | France |
PTGX Protagonist Therapeutics Inc | 723.25 k | 25.00 k shares | 0.70 | Common equity | Long | USA |
DYN Dyne Therapeutics Inc | 567.80 k | 20.00 k shares | 0.55 | Common equity | Long | USA |
VALN Valneva SE | 495.41 k | 62.00 k shares | 0.48 | Common equity | Long | France |
NUVB Nuvation Bio Inc - Ordinary Shares | 491.40 k | 135.00 k shares | 0.48 | Common equity | Long | USA |
ALPMY Astellas Pharma Inc | 456.88 k | 42.50 k shares | 0.44 | Common equity | Long | Japan |
AUPH Aurinia Pharmaceuticals Inc | 400.80 k | 80.00 k shares | 0.39 | Common equity | Long | Canada |
GILD Gilead Sciences, Inc. | 256.38 k | 3.50 k shares | 0.25 | Common equity | Long | USA |
IMTX Immatics N.V | 183.93 k | 17.50 k shares | 0.18 | Common equity | Long | Netherlands |
VRDN Viridian Therapeutics Inc | 105.06 k | 6.00 k shares | 0.10 | Common equity | Long | USA |
VTYX Ventyx Biosciences Inc | 55.00 k | 10.00 k shares | 0.05 | Common equity | Long | USA |
CGON Cg Oncology Inc. | 43.90 k | 1.00 k shares | 0.04 | Common equity | Long | USA |
FID-MM GOVT-I | 1.40 | 1.40 principal | 0.00 | Short-term investment vehicle | Long | USA |